简体中文

论著-头颈部

研究浸润性宫颈癌术前CT及MRI诊断的临床价值

作者:李留灿

所属单位:河南省新郑市人民医院CT/MRI室 (河南 新郑 451100)

PDF

摘要

目的 探讨浸润性宫颈癌术前CT及MRI诊断的临床价值。方法 选择2015年1月-2017年1月我院收治的52例浸润性宫颈 癌患者,对其影像学资料进行回顾性分析。本组均于术前采取CT与MRI检查,观察对比两种检查方法(CT与MRI)对 浸润性宫颈癌的诊断符合率。结果 MRI对浸润性宫颈癌Ⅱ期的诊断符合率与总符合率100.00%、96.15%,高于CT的 54.55%、76.92%(P<0.05)。MRI与CT对浸润性宫颈癌Ⅲ期与Ⅳ期的诊断符合率对比差异无统计学意义(P>0.05)。结 论 相较于CT,MRI对于浸润性宫颈癌的术前诊断效果更佳,临床应用价值显著,适于推广。

Objective To investigate the clinic value of preoperative CT and MRI on diagnosing invasive cervical cancer. Methods 52 cases with invasive cervical cancer in our hospital from January 2015 to January 2017 were selected and their imaging data were retrospectively analyzed. The two groups were all given CT and MRI examination before surgery, observe and compare the diagnostic accordance rate of the two examination methods (CT and MRI) on invasive cervical cancer. Results The diagnostic coincidence rate and total coincidence rate of MRI to stage II of invasive cervical cancer were 100.00% and 96.15%, higher than 54.55% and 76.92% of CT (P<0.05). There was no significant difference between MRI and CT in the diagnostic coincidence of stage III and IV of invasive cervical cancer (P>0.05). Conclusion MRI has better preoperative diagnostic effect on invasive cervical cancer than CT and MRI has significant clinic effect and is suitable for promotion

【关键词】浸润性宫颈癌;术前;CT;MRI;诊断价值

【中图分类号】R711.74

【文献标识码】A

【DOI】10.3969/j.issn.1009-3257.2018.01.025

前言

宫颈癌属于临床常见的恶性肿瘤,近年来,随着 人们生活方式的改变,该病的发生率也呈显著上升的 趋势。据相关调查显示,全球每年宫颈癌的新发病 例为46.5万例,而我国每年新发病例已超过13.15万 例,现已成为全社会关注的焦点问题[1]。目前,尽早 诊断与治疗宫颈癌是强化患者预后的重点。虽然宫颈 癌术前分期可以有效指导临床治疗方案,但对于宫旁 浸润性病灶却存在一定的局限性,而影像学技术却在 此方面显示出了一定的优势,能够反映出宫旁浸润的 情况[2]。为了进一步完善浸润性宫颈癌患者的诊疗效 果,本研究对2015年1月~2017年1月我院52例浸润性 宫颈癌患者的影像资料进行分析,探讨浸润性宫颈癌 术前CT及MRI诊断的临床价值,现报道如下。